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Health impact of infectious agents
----------------------------------

Even today, infections claim nearly 15 million lives per year around the globe \[[@R8]\]. This is most likely a gross underestimation because the true cause of death remains undetermined in many cases. Moreover, we now know that infectious agents can be important primary or co-factors in many chronic and acute causes of death \[[@R1]\]. In addition, we continue to discover new pathogens \[[@R6]\] whose combined contribution to human fatalities remains unknown. Therefore, the true burden of microbial pathogens on our health and economy is certainly far greater than currently realized. Why should this be so in today's world? Quite paradoxically, 'modernization' has increased our exposure and vulnerability to many infectious agents \[[@R5]\]. In general terms, the heavy reliance on chemotherapy has not served us well; instead, its backlash could seriously undermine much of the progress of the past several decades.

In spite of the emergence/re-emergence of pathogens, there is little progress in developing safe and affordable anti-infectives in the past 40 years; the same applies to vaccines as well. Indeed, the rates of childhood vaccinations are falling, partly because many young parents have no memory of the damage infections such as poliomyelitis can cause in children. In addition, there are concerns, justified or not, with the safety of many childhood vaccines. This continuing decrease in the rate of childhood vaccinations may well see the return of many infectious diseases. Poliomyelitis is a good example here; it was at the verge of eradication then parents succumbed to the rumour that the vaccine rendered girls infertile \[[@R3]\].

Barring a major breakthrough or two, one simply cannot conceive of having safe and effective drugs and/or vaccines available against some 1 500 known human pathogens (Taylor et al. 2003). Even if such a dream were to be realized, it still would not undermine the significance of good environmental and personal hygiene in our daily lives to *prevent* the spread of common infections. For example, simple and inexpensive measures such as hand hygiene and preparing baby's milk formula from clean water could save many lives even in the absence of vaccination against rotaviruses and many other enteric pathogens (Saidi et al. 1997). Women in cholera-endemic areas can reduce the risk of waterborne infection by the simple hygienic practice of passing polluted surface waters through several fold of the *sari* cloth to filter out *Vibrio cholerae*-containing planktons \[[@R2]\].

Microbicides and environmental control of pathogens
---------------------------------------------------

Whether we realize it or not, there is heavy reliance on microbicides in many aspects of our daily lives. Indeed, the relative significance of microbicides in infection prevention and control is on the rise with increasing antibiotic resistance. For example, many patients with MRSA-colonized skin can no longer with treated with antibiotics but must have a microbicidal ointment applied to the body surface several times a week to clear up the colonization. Hospitals must use environmental surface disinfectants to reduce the risk of nosocomial infections with pathogens such as *Clostridium difficile* \[[@R4]\] and norovirus. The use of alcohol-based handrubs in healthcare and other settings is now widely accepted even in North America.

Emerging issues
---------------

We cannot ignore the fact that many chemicals used as microbicides can be unsafe for humans as well as the environment. This is leading to a closer scrutiny of formulations containing such ingredients. Flaws have also been identified in common methods to assess the microbicidal activities of chemicals \[[@R7]\].

With the shrinking numbers of therapies at our disposal, there is enhanced reemphasis on preventive strategies, including the use of microbicides in environmental control. But, the increasing reliance on microbicides could precipitate a whole new series of problems if their use is not approached with care. We also need a greater effort to better understand the means of spread of many common pathogens. For examples, we still lack knowledge on the major modes of spread, portals of entry and the relative significance of vehicles such as water, food and air in the spread of pathogens such as rotaviruses and noroviruses. Without this information, any attempt at their environmental control is no more than a 'shot in the dark'.

Quite often, we adopt new technologies without any thought on how they may promote the environmental survival and spread of frank and opportunistic pathogens. For example, many municipalities are switching to chloramination of drinking water to avoid potentially toxic by-products of chlorination (Simmons et al. 2002). There is now evidence suggesting that this change in disinfectants can influence the microbial ecology of biofilms in drinking water distribution systems with increases in environmental mycobacteria (Pryor et al. 2003). Could this measure to improve the chemical quality favour the spread of opportunistic pathogens through municipally treated drinking water?

Concluding remarks
------------------

Microbial pathogens will continue to be with us for a long time to come. There are many more of them; their generation time is relatively short and their genomes also much simpler. In this day and age, we subject them to increasing selective pressures, thus forcing them to evolve into forms resistant to antimicrobials and vaccines. This clearly suggests that, for the long term, our current emphasis on treatment and vaccination strategies must be blended better with preventive approaches. Unlike chemotherapy and vaccination, properly designed and applied preventive measures can apply to a much wider variety of pathogens and also be less site-specific.
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